Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2

Journal of Virology(2020)10.1128/jvi.00562-20Source: DataRank Database

LY6E Restricts Entry of Human Coronaviruses, Including Currently Pandemic SARS-CoV-2 is a research paper published in Journal of Virology (2020). On theSindex it has a DataRank of 0. It has been cited 100 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access100 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 1.83)OA: hybridTopics (81)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (10)

Shuangli Zheng,Danying Chen ORCID,Mei Zheng ORCID,Xinglin Li ORCID,Guoli Li ORCID

Live enrichment

PubMed:32641482 PMC:PMC7459569 OpenAlex:https://openalex.org/W3041763853

HHS | National Institutes of Health

Grant: AI113267

National Science Foundation of China

Grant: 81772173

National Science Foundation of China

Grant: 81971916

NIAID NIH HHS

Grant: R01 AI113267

National Institutes of Health

Grant: 5R01AI113267-06

Evaluation of therapeutic benefits of HBV nucleocapsid assembly inhibitors

FWCI

1.83

Citation Percentile

0.9%

Influential Citations

Citation Trend

2019

2020

2021

2022

2023

2024

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1128/jvi.00562-20

HYBRIDhttps://doi.org/10.1128/jvi.00562-20

publisherhttps://doi.org/10.1128/jvi.00562-20

publisherhttps://journals.asm.org/doi/pdf/10.1128/JVI.00562-20

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32641482

Fields of Study

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studiesCOVID-19 Clinical Research StudiesMedicineBiology0301 basic medicine03 medical and health sciences0303 health sciencesAmino Acid SequenceAmphotericin BAntigens, SurfaceBetacoronavirusCOVID-19Cell LineCoronavirusCoronavirus InfectionsDisease SusceptibilityEvolution, MolecularGPI-Linked ProteinsHost-Pathogen InteractionsHumansPandemicsPneumonia, ViralProtein Sorting SignalsSARS-CoV-2Spike Glycoprotein, CoronavirusVirus Internalization

MeSH Terms

BetacoronavirusCOVID-19SARS-CoV-2Amino Acid SequenceAmphotericin BAntigens, SurfaceCell LineDisease SusceptibilityHumansPneumonia, ViralCoronavirusCoronavirus InfectionsEvolution, MolecularProtein Sorting SignalsVirus InternalizationHost-Pathogen InteractionsGPI-Linked ProteinsPandemicsSpike Glycoprotein, Coronavirus

Keywords

BiologyPandemicSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Virology2019-20 coronavirus outbreakBetacoronavirusCoronavirusCoronavirus InfectionsOutbreakInfectious disease (medical specialty)DiseaseViral EntryLy6eHuman CoronavirusSars-cov-2ImmunologyPneumonia, ViralProtein Sorting SignalsGPI-Linked ProteinsMicrobiologyCell LineEvolution, MolecularAmphotericin BHumansAmino Acid SequencePandemicsCOVID-19Virus InternalizationVirus-Cell InteractionsInsect ScienceAntigens, SurfaceHost-Pathogen InteractionsSpike Glycoprotein, CoronavirusDisease Susceptibility

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being